EIR Teva Parenteral Manufacturing Apr 2012

Jennifer Gogley FDA, Carla Lundi FDA, Caryn Mcnab FDA, Bichsa Tran FDA$595.00 - Available Now

FDA investigators audited the Teva Parenteral Manufacturing - Irvine, CA, United States facility and issued inspectional observation (via FDA 483) on 24 Apr 2012.

Product details

  • Category:
  • Inspection end: 24 Apr 2012
  • Location: Irvine, United States
  • FEI: 2027158
Add To Cart